$2.67 - CATX | Perspective Therapeutics, Inc.

Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics, Inc.

XASE:CATX

2.67

4.71%

Ask

$2.74 - 929.00

Bid

$2.45 - 100.00

Low

$2.53

High

$2.73

Open

$2.56

Prev Close

$2.55

52W High

5.39

52W Low

1.6

Volume

1185408

Avg Vol (3m)

1460973.5

Float

61649469.79

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 3841

Sector: Health Technology

Industry: Medical Specialties

Date Listed: 12/29/2003

Primary Exchange: XASE

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Phone: 206-676-0900

Address: 2401 Elliott Avenue

Address 2: Suite 320

City: Seattle

State: WA

Postal Code: 98121

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

140

P/E (TTM)

-1.830000

P/B (TTM)

0.819443

Round Lot

100

Composit FIGI

BBG000BG5HT7

Share Class FIGI

BBG001S5Q300

Share Class Shares Outstanding

74.26M

Weighted Shares Outstanding

74.26M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion